About Nevro Corp

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. HF10 therapy has demonstrated the ability to reduce or eliminate opioids in =65% of patients across six peer-reviewed clinical studies. The Senza® System, Senza II™ System, and the Senza® Omnia™ System are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Senza, Senza II, Senza Omnia, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.

CEO

D.Keith Grossman

Employees

843

Headquarters

1800 Bridge Pkwy
Redwood City, California 94065-1164
Phone: 16502510005
www.nevro.com

News

Nevro considers sale as competition for pain market ramps up
Aug 08, 2024 20:34pm

… Potential opportunities include “partnerships, mergers or even a sale of … Scientific and Medtronic, as a potential acquisition target for years. … top 25 potential medtech acquisition targets due to its … from getting SCS therapy as well as competing for our …

Source:EIN News Merge and Acquisitions

Nevro plunges as revised guidance draws downgrades
Aug 07, 2024 18:59pm

No summary available.

Source:Seeking Alpha

Wells Fargo downgrades Nevro Corp stock to Underweight, slashes PT
Aug 07, 2024 15:09pm

https://www.investing.com/news/company-news/wells-fargo-downgrades-nevro-corp-stock-to-underweight-slashes-pt-93CH-3560050

Source:Investing.com

Nevro Corp. (NVRO) Q2 2024 Earnings Call Transcript
Aug 07, 2024 09:54am

Nevro Corp. (NYSE:NYSE:NVRO) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ETCompany ParticipantsAngie McCabe - VP, IR & Corporate…

Source:Seeking Alpha

JPMorgan sees tough road ahead for Nevro stock
Aug 07, 2024 07:23am

https://www.investing.com/news/company-news/jpmorgan-sees-tough-road-ahead-for-nevro-stock-93CH-3558517

Source:Investing.com

Nevro Corp (NVRO) Q2 2024 Earnings Call Transcript Highlights: Revenue Decline Amid Strategic ...
Aug 07, 2024 07:14am

Nevro Corp (NVRO) Q2 2024 Earnings Call Transcript Highlights: Revenue Decline Amid Strategic Review and Market Challenges

Source:GuruFocus

Nevro: Q2 Earnings Snapshot
Aug 06, 2024 20:51pm

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Nevro Corp. (NVRO) on Tuesday reported a loss of $19.6…

Source:WTOP

Nevro Corp. 2024 Q2 - Results - Earnings Call Presentation
Aug 06, 2024 20:50pm

The following slide deck was published by Nevro Corp.

Source:Seeking Alpha

Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024
Jul 09, 2024 20:15pm

REDWOOD CITY, Calif., July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial results for the second quarter of 2024 after…

Source:PR Newswire